开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-09-04 ms8000001052932104 来自江苏省

偏重的研究方向：外科
经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation

7 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-05-09 Eureka Mi 来自四川省

偏重的研究方向：外科
经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-10-22 ms8000000504841700 来自山东省

偏重的研究方向：外科;普外科;胃肠
经验分享：文章接收很快，从投到接收三个月

97 0

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-04-03 独行er

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：外科
经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。
但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated.
应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀

109 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-05-31 drop13 来自上海

审稿速度:6.0 | 投稿命中率:75.0
经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。

104 0

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-11-05 1def03bbm67(暂无匿称)

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：临床与病理结合;临床
经验分享：2022.6.11 Awaiting Admin Processing
2022.6.18 Under review
2022.6.20 Under Review
2022.8.11 Awaiting EIC Decision
2022.8.16 Minor Revision
2022.9.13 Resubmit
2022.9.13 Awaiting Admin Processing
2022.9.23 Under Review
2022.11.1 Awaiting EIC Decision
2022.11.5 Accept

114 0

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-06-28 独行er

最新 IF 3.07，好悬

109 0

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-05-06 ms5000001369153496

偏重的研究方向：文献计量学
经验分享：Awaiting Admin Processing 11天了什么情况啊

101 0

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-03-09 winterlegend

审稿速度:2.0
经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept

268 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2224071, encodeId=ea5522240e14c, content=偏重的研究方向：外科 经验分享：Jun 12 2024 Submit Jun 14 2024 Under Review Sep 04 2024 Pending Recommendation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Sep 04 20:17:26 CST 2024, time=2024-09-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2203665, encodeId=1c05220366513, content=偏重的研究方向：外科 经验分享：Apr 28 2024 submitted Apr 30 2024 Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7528594085, createdName=Eureka Mi, createdTime=Thu May 09 13:24:07 CST 2024, time=2024-05-09, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2164169, encodeId=38ac21641697b, content=偏重的研究方向：外科;普外科;胃肠 经验分享：文章接收很快，从投到接收三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2be8562513, createdName=ms8000000504841700, createdTime=Sun Oct 22 09:29:21 CST 2023, time=2023-10-22, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208316, encodeId=cde51208316a4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：前后2月余，小修一次，今天收到接收函。今年应该还在3分以上。 但是，接收函里有这么一句：has been accepted in its current form for publication in the World Journal of Surgery contingent upon a Crosscheck scan. After acceptance, all WJS material is put through a computer search comparing the new material with all previously published scientific work. We will contact you if any significant "overlap" is demonstrated. 应该是接收后还要查重。我自己查了一下，发现和自己以前的一篇文章重复率4%（捂脸ing），都是方法学部分里的句子。好担心呀。大家有没有相同的经历呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Sun Apr 03 10:34:07 CST 2022, time=2022-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140170, encodeId=3bb321401e014, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：杂志审稿挺快的，主要是我自己有点拖。就是accept之后已经两个月了多，也不知道如何了。因为接收信里说还要查重。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ad82999046, createdName=drop13, createdTime=Wed May 31 21:19:12 CST 2023, time=2023-05-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2098768, encodeId=66d72098e6870, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：临床与病理结合;临床 经验分享：2022.6.11 Awaiting Admin Processing 2022.6.18 Under review 2022.6.20 Under Review 2022.8.11 Awaiting EIC Decision 2022.8.16 Minor Revision 2022.9.13 Resubmit 2022.9.13 Awaiting Admin Processing 2022.9.23 Under Review 2022.11.1 Awaiting EIC Decision 2022.11.5 Accept , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14131732842, createdName=1def03bbm67(暂无匿称), createdTime=Sat Nov 05 22:21:03 CST 2022, time=2022-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229258, encodeId=9e5e12292586d, content=最新 IF 3.07，好悬, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5cd32801854, createdName=独行er, createdTime=Tue Jun 28 20:49:10 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217458, encodeId=d194121e45816, content=偏重的研究方向：文献计量学 经验分享：Awaiting Admin Processing 11天了什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a7e5696898, createdName=ms5000001369153496, createdTime=Fri May 06 22:36:26 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586210, encodeId=6cff586210ce, content=审稿速度:2.0 经验分享：2019.12.15 Awaiting Admin Processing 2019.12.22 under review 2020.2.11 Awaiting EIC Decision 2020.2.16 Reject & Resubmit 2020.2.20 Resubmit 2020.2.20 Awaiting Admin Processing 2020.2.20 Under Review 2020.3.1 Awaiting EIC Decision 2020.3.1 Accept 2020.3.1 Awaiting Production Checklist 2020.3.3 Awaiting Assignment to Batch 2020.3.3 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231202/f5d54a76129e4a5880bb7e96cd04be64/2b678d90720348f68ac1a3082a7047cc.jpg, createdBy=1fd31636241, createdName=winterlegend, createdTime=Mon Mar 09 00:00:00 CST 2020, time=2020-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1099573, encodeId=c9b110995e3bc, content=上传文章有什么要求？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

上传文章有什么要求？

115 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务